[1]来佑青 王丽 刘仲奇 闫燕 李丽娟 杜晨 李涛曾进**.术腔置入脱细胞异体真皮基质预防腮腺术后Frey综合征[J].中国微创外科杂志,2019,01(11):1016-1031.
　Lai Youqing,Wang Li,Liu Zhongqi,et al.Acellular Dermal Matrix Implantation in Operation Cavity for Preventing Frey’s Syndrome After Parotid Gland Surgery[J].Chinese Journal of Minimally Invasive Surgery,2019,01(11):1016-1031.
点击复制

术腔置入脱细胞异体真皮基质预防腮腺术后Frey综合征()
分享到：

《中国微创外科杂志》[ISSN:1009-6604/CN:11-4526/R]

卷:
01
期数:
2019年11期
页码:
1016-1031
栏目:
临床研究
出版日期:
2019-11-25

文章信息/Info

Title:
Acellular Dermal Matrix Implantation in Operation Cavity for Preventing Frey’s Syndrome After Parotid Gland Surgery
作者:
来佑青 王丽 刘仲奇 闫燕 李丽娟 杜晨 李涛曾进**
（北京大学第三医院耳鼻咽喉科，北京100191）
Author(s):
Lai Youqing;  Wang Li;  Liu Zhongqi;  et al.
Department of Otolaryngology, Peking University Third Hospital, Beijing 100191, China
关键词:
腮腺手术; 脱细胞异体真皮基质; Frey综合征
Keywords:
Parotid gland surgery; Acellular dermal matrix; Frey’s syndromeFrey
文献标志码:
A
摘要:
目的探讨脱细胞异体真皮基质（acelluar dermal matrix, ADM）置入腮腺术腔预防腮腺术后Frey综合征的临床效果。方法将2010年1月~2018年3月89例腮腺手术按患者意愿分实验组（44例）和对照组（45例），实验组术腔置入ADM，对照组未置入任何组织材料。术后半年以调查问卷方式对患者有无Frey综合征症状、Frey综合征发生时间以及对生活的影响进行评价。结果实验组随访7~106个月，中位随访时间23.5月；对照组随访16~90个月，中位随访时间40个月。实验组腮腺手术后Frey综合征发生率2.3%（1/44），明显低于对照组42.2%（19/45）（χ2=26.978，P=0.000）。20例Frey综合征经合理解释与沟通均未进一步治疗,4例（20%）认为Frey综合征对自己的生活无明显影响，其余16例（80%）认为Frey综合征对自己的生活影响较明显或非常明显。结论术腔置入ADM明显降低腮腺术后Frey综合征的发生率，具有满意的预防效果。
Abstract:
ObjectiveTo evaluate the clinical effect of acellular dermal matrix（ADM） implantation in operation cavity for the prevention of Frey’s syndrome after parotid gland surgery.MethodsA total of 89 patients receiving parotid gland surgery from January 2010 to March 2018 were divided into either experimental group (44 patients) or control group (45 patients) according to patients’ willing. The experimental group was implanted with ADM. The control group was not implanted with any tissue materials. The incidence rate of Frey’s syndrome, the time of Frey’s syndrome, and its impact on life were evaluated. ResultsThe experimental group was followed up for 7-106 months(median,23.5 months).The control group was followed up for 16-90 months (median,40 months).The incidence of Frey’s syndrome in the experimental group was 2.3%(1/44),which was significantly lower than 42.2%(19/45) in the control group (χ2=26.978, P=0.000). After reasonable explanation and communication, no further treatment was carried out for Frey’s syndrome in 20 patients. Four patients (20%) thought that Frey’s syndrome had no significant impact on their own lives, and the other 16 patients (80%) thought that Frey’s syndrome had significant or very significant impact on their own lives.ConclusionADM implantation in operation cavity significantly reduces the incidence of Frey’s syndrome after parotid gland surgery, having a satisfactory preventive effect.

参考文献/References:

[1]郝智，崔建英.腮腺肿瘤术后Frey综合征的发病机制和防治措施.现代肿瘤医学，2008,6(12):2239-2241.
[2]余光岩，高岩，孙永刚，主编.口腔颌面部肿瘤.北京：人民卫生出版社,2002.172.
[3]Sinha UK，Saadat D，Doherty CM, et al. Use of AlloDerm implant to prevent Frey’s syndrome after parotidectomy. Arch Facial Plast Surg,2003,5(1):109-113.
[4]黄选兆，汪吉宝，孔维佳,主编.第2版.实用耳鼻咽喉头颈外科学.北京：人民卫生出版社，2007.645.
[5]周建华,邱建忠,陈正岗,等.预防腮腺术后Frey综合征的临床比较研究.口腔医学杂志，2014,34(6):435-437.
[6]Bonanno PC, Palaia D, Rosenberg M, et al. Prophylaxis against Frey’s syndrome in parotid surgery. Ann Plast Surg,2000,44(5):498-501.
[7]Eckardt A, Kuettner C. Treatment of gustatory sweating (Frey’s syndrome) with botulinum toxin A. Head Neck,2003,25(8):624-628.
[8]Rubinstein RY, Rosen A, Leeman D. Frey syndrome: treatment with temporoparietal flap interposition. Arch Otolaryngol Head Neak Surg,1999,125(7):808-811.
[9]Arad Cohen A, Blitzer A. Botulinum toxin treatment for symptom atic Frey’s syndrome. Otolaryngol Head Neek Surg,2002,122(2):237-240.
[10]孙海鹏，冯力，翁汝莲，等.脱细胞异体真皮基质预防腮腺切除术后Frey综合征和面部凹陷的临床研究.广东牙病防治，2008，16（4）:161-163.
[11]赵娴，刘流，赫佳，等.面部除皱切口和胸锁乳突肌瓣转移整复术在腮腺全叶切除术中的应用.口腔医学研究，2010，26（5）:724-726.
12Teknos TN, Nussenbaum B, Bradford CR, et al. Reconstruction of complex parotidectomy defects using the lateral arn free tissue transfer. Otolaryngol Head Neck Surg,2003,129(3):183-191.
[13]Cesteleyn L, Helman J, King S, et al. Temporoparietal fascia flaps and superficial musculoaponeurotic system plication in parotid surgery reduces Frey’s syndrome. Oral Maxillofac Surg,2002,60(11):1297-1298.
[14]韩立显，马新亮，朱守莉，等.胸锁乳突肌瓣联合异体脱细胞真皮基质预防腮腺部分切除术后Frey综合征的临床观察.蚌埠医学院学报,2015,40（3）:345-347.
[15]Linc CC, Tsai MH，Huang CC, et al. Parotid tumors: a 10 year experience. Am J Otolaryngol,2008,29(2):94-100.
[16]顾洪波，赵恩民，肖水芳，等.腮腺区域性切除术在腮腺良性肿瘤治疗中的临床价值.临床耳鼻咽喉头颈外科杂志,2018,32（9）：669-672.
[17]Dulguerov P, Quinodoz D, Cosendai G. Prevention of Frey’s syndrome during parotiectomy. Arch Otolaryngol Head Neck Surg,1999,125(8):833-839.
[18]Sverzut CE, Trivellato AE, Serra EC, et al. Frey syndrome after condylar fracture case report. Braze Dent,2004,15(2):159-162.
[19]许彪，王卫红，范红渠，等.旋转腮腺筋膜瓣预防腮腺术后味觉出汗综合征.实用口腔医学杂志，2005，21（1）:135-136.
[20]姚泰,主编.生理学.第6版.北京:人民卫生出版社，2003.319.
[21]叶为民，竺涵光，王旭东，等.脱细胞异体真皮在预防腮腺手术后Frey综合征中的作用.中国口腔颌面外科杂志，2006，6（4）:420-422.

备注/Memo

备注/Memo:
基金项目：北京大学医工交叉项目（BMU2018ME004）**通讯作者，Email：dr_zengjin@126.com
更新日期/Last Update: 2020-03-03